Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Original article

Ahead-of-Print

Seroprevalence study of West Nile virus and Usutu virus in blood, organs, cells and tissue donors in Italy, 2021-2022

Authors

Antonello Amendola , Stefano Boros , Ilaria Pati , Letizia Lombardini , Cristiano Fiorentini , Claudia Fortuna , Antonino Bella , Raffaele Donadio , Giulia Marsili , Claudio Argentini , Vanessa Piccinini , Francesca Masiello , Giuseppe Feltrin , Simonetta Pupella , Vincenzo De Angelis , Flavia Riccardo , Patrizio Pezzotti , Giulietta Venturi

Key words: West Nile virus, Usutu virus, Seroprevalence, blood donors, Organ Donors
DOI: 10.2450/BloodTransfus.1079
Transfusion transmitted diseases
Publication Date: 2025-09-05

Abstract

Background - West Nile virus (WNV) and Usutu virus (USUV) are endemic in Italy. Some regions experience high annual circulation, while others report only sporadic or low-level activity.

Materials and methods - A national survey was conducted to assess WNV and USUV seroprevalence among blood and organ donors. Between February 2021 and February 2022, serum samples were collected from 9,073 donors (8,829 blood donors and 244 organ donors) across almost all Italian regions. Samples were screened using a WNV ELISA IgG test, with positive results confirmed via plaque reduction neutralization test (PRNT) for WNV and USUV.

Results - Of the total samples, 195 (190 blood donors and 5 organ donors) tested positive by ELISA. Among these, 23 samples (20 blood donors and 3 organ donors) were confirmed WNV-positive, and 42 (41 blood donors and 1 organ donor) were USUV-positive by PRNT. Additionally, 39 donors had antibodies to both viruses.

Unadjusted national seroprevalence among blood donors was 0.66% (95% CI: 0.50-0.85%) for WNV and 0.90% (95% CI: 0.71-1.11%) for USUV. Among organ donors, WNV seroprevalence was 1.64% (95% CI: 0.45-4.14%) and 0.82% (95% CI: 0.10-2.93%) for USUV. After adjustment by general population weights, national seroprevalence in blood donors was 0.90% for WNV and 1.16% for USUV.

Discussion - Seroprevalence was higher in historically endemic northern regions, aligning with known circulation patterns. Blood and organ donors showed similar exposure levels. These findings confirm sustained WNV and USUV presence in Italy and support the continued need for preventive safety measures in the management of Substances of Human Origin (SoHO).

Downloads

pdf
Authors

Antonello Amendola - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy https://orcid.org/0000-0003-1114-6817

Stefano Boros - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Ilaria Pati - National Blood Centre, Italian National Institute of Health, Rome, Italy https://orcid.org/0000-0003-4846-2338

Letizia Lombardini - Italian National Transplant Centre, National Institute of Health, Rome, Italy

Cristiano Fiorentini - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Claudia Fortuna - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Antonino Bella - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Raffaele Donadio - Italian National Transplant Centre, National Institute of Health, Rome, Italy

Giulia Marsili - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Claudio Argentini - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Vanessa Piccinini - National Blood Centre, Italian National Institute of Health, Rome, Italy https://orcid.org/0000-0002-3763-0271

Francesca Masiello - National Blood Centre, Italian National Institute of Health, Rome, Italy https://orcid.org/0000-0003-3901-1199

Giuseppe Feltrin - Italian National Transplant Centre, National Institute of Health, Rome, Italy

Simonetta Pupella - National Blood Centre, Italian National Institute of Health, Rome, Italy

Vincenzo De Angelis - National Blood Centre, Italian National Institute of Health, Rome, Italy

Flavia Riccardo - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Patrizio Pezzotti - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy

Giulietta Venturi - Department of Infectious Diseases, Italian National Institute of Health, Rome, Italy https://orcid.org/0000-0002-9078-8350

  • Abstract viewed - 613 times
  • pdf downloaded - 170 times